Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000886163-25-000012
Filing Date
2025-02-28
Accepted
2025-02-28 16:02:16
Documents
112
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K lgnd-20241231.htm   iXBRL 10-K 2710534
2 EX-19.1 exhibit191_insidertradingc.htm EX-19.1 101874
3 EX-21.1 lgnd_123124xexhibit211.htm EX-21.1 8625
4 EX-23.1 lgnd_123124xexhibit231.htm EX-23.1 6332
5 EX-31.1 lgnd_123124xexhibit311.htm EX-31.1 15839
6 EX-31.2 lgnd_123124xexhibit312.htm EX-31.2 15829
7 EX-32.1 lgnd_123124xexhibit321.htm EX-32.1 13044
13 lgnd-20241231_g1.jpg GRAPHIC 39695
14 lgnd-20241231_g2.jpg GRAPHIC 166240
15 lgnd-20241231_g3.jpg GRAPHIC 101471
16 lgnd-20241231_g4.jpg GRAPHIC 384460
  Complete submission text file 0000886163-25-000012.txt   17059526

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lgnd-20241231.xsd EX-101.SCH 100358
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lgnd-20241231_cal.xml EX-101.CAL 171308
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lgnd-20241231_def.xml EX-101.DEF 638308
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lgnd-20241231_lab.xml EX-101.LAB 1312641
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lgnd-20241231_pre.xml EX-101.PRE 940313
115 EXTRACTED XBRL INSTANCE DOCUMENT lgnd-20241231_htm.xml XML 2327738
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33093 | Film No.: 25689885
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)